These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8649778)

  • 1. Synergism between two growth regulatory pathways: cooperative transformation of NIH3T3 cells by G alpha 12 and c-raf-1.
    Zhang Y; Saez R; Leal MA; Chan AM
    Oncogene; 1996 Jun; 12(11):2377-83. PubMed ID: 8649778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
    Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. smg/rap1/Krev-1 p21s inhibit the signal pathway to the c-fos promoter/enhancer from c-Ki-ras p21 but not from c-raf-1 kinase in NIH3T3 cells.
    Sakoda T; Kaibuchi K; Kishi K; Kishida S; Doi K; Hoshino M; Hattori S; Takai Y
    Oncogene; 1992 Sep; 7(9):1705-11. PubMed ID: 1323817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G2A is an oncogenic G protein-coupled receptor.
    Zohn IE; Klinger M; Karp X; Kirk H; Symons M; Chrzanowska-Wodnicka M; Der CJ; Kay RJ
    Oncogene; 2000 Aug; 19(34):3866-77. PubMed ID: 10951580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An essential role for Rac in Ras transformation.
    Qiu RG; Chen J; Kirn D; McCormick F; Symons M
    Nature; 1995 Mar; 374(6521):457-9. PubMed ID: 7700355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.
    Crespo P; Bustelo XR; Aaronson DS; Coso OA; Lopez-Barahona M; Barbacid M; Gutkind JS
    Oncogene; 1996 Aug; 13(3):455-60. PubMed ID: 8760286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
    Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
    Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. R-Ras is regulated by activators and effectors distinct from those that control Ras function.
    Huff SY; Quilliam LA; Cox AD; Der CJ
    Oncogene; 1997 Jan; 14(2):133-43. PubMed ID: 9010215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TC21 and Ras share indistinguishable transforming and differentiating activities.
    Graham SM; Oldham SM; Martin CB; Drugan JK; Zohn IE; Campbell S; Der CJ
    Oncogene; 1999 Mar; 18(12):2107-16. PubMed ID: 10321735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
    Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of evidence for the activation of the Ras/Raf mitogenic pathway by 14-3-3 proteins in mammalian cells.
    Suen KL; Bustelo XR; Barbacid M
    Oncogene; 1995 Sep; 11(5):825-31. PubMed ID: 7675443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
    Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
    Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative transformation of NIH3T3 cells by G alpha12 and Rac1.
    Tolkacheva T; Feuer B; Lorenzi MV; Saez R; Chan AM
    Oncogene; 1997 Aug; 15(6):727-35. PubMed ID: 9264413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins.
    Movilla N; Crespo P; Bustelo XR
    Oncogene; 1999 Oct; 18(43):5860-9. PubMed ID: 10557073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM; Pegg AE
    Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase.
    Cacace AM; Ueffing M; Philipp A; Han EK; Kolch W; Weinstein IB
    Oncogene; 1996 Dec; 13(12):2517-26. PubMed ID: 9000126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways.
    Martin CB; Mahon GM; Klinger MB; Kay RJ; Symons M; Der CJ; Whitehead IP
    Oncogene; 2001 Apr; 20(16):1953-63. PubMed ID: 11360179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic activation of c-fos promoter activity by Raf and Ral GDP dissociation stimulator.
    Okazaki M; Kishida S; Hinoi T; Hasegawa T; Tamada M; Kataoka T; Kikuchi A
    Oncogene; 1997 Feb; 14(5):515-21. PubMed ID: 9053849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.